RATCHAPHRUEK HOSPITAL PUBLIC COMPANY LIMITEDSET: RPH🇹🇭 TH

CG Policy · 2025

Corporate Governance Policy

Introduction

The Board of Directors is committed to upholding high standards of good corporate governance while conducting business with integrity, respect for human rights, and responsibility toward society, the environment, and all stakeholders. The Board firmly believes that good corporate governance is a key driver of sustainable value creation, transparency, accountability, and ethical competitiveness amid a rapidly evolving business environment.

The Company places importance on delivering sustainable value and appropriate returns to shareholders, while simultaneously creating long-term benefits for society, communities, and the environment. Maintaining credibility and strengthening stakeholder confidence remain fundamental objectives of the Board’s governance approach.

The Board of Directors has established and implemented a Good Corporate Governance Policy as a guiding framework for organizational practices. The policy is reviewed and continuously improved to align with the principles of good corporate governance for listed companies and to enhance the effectiveness of the Board’s oversight responsibilities.

At the Board of Directors’ Meeting No. 4/2025, held on November 8, 2025, the Board approved a review and revision of the Company’s Good Corporate Governance Policy. Further details are available on the Company’s website under the “Corporate Governance” section.

Corporate Governance Framework

The Company’s corporate governance policy framework is structured into five key categories:

  1. Shareholders’ Rights

  2. Equitable Treatment of Shareholders

  3. Roles of Stakeholders

  4. Disclosure and Transparency

  5. Responsibilities of the Board of Directors

The Board has oversee governance practices, maintain standards, and regularly review and enhance policies in accordance with the Good Corporate Governance Principles for Listed Companies (Revised 2017) issued by the Stock Exchange of Thailand.

Governance KPI Dashboard

To demonstrate measurable corporate governance outcomes, the Company has established a Governance KPI Dashboard to monitor the effectiveness of board oversight, ethical conduct, and compliance practices. These indicators are integrated with the Company’s risk management and internal control framework.

Governance KPI Dashboard

  • Board Meeting Attendance ≥ 95%

  • Ethics & Corporate Governance Training Completion: 100%

  • Zero Insider Trading Case

  • Whistleblowing Response Rate ≥ 95%

  • Ethics & Compliance Reporting to the Board at least once per year

These KPIs serve as key governance performance indicators to support continuous improvement and reinforce the Company’s commitment to transparency, accountability, and sustainable corporate governance.

Has a Corporate Governance Policy

Yes

Policy Description

Implementation of Good Corporate Governance Practices

The Board of Directors recognizes the importance of the Good Corporate Governance Principles for Listed Companies (Revised 2017) issued by the Stock Exchange of Thailand. The Company has therefore adopted these principles as a framework for organizational management to strengthen operational efficiency, transparency, accountability, and to build sustainable confidence among shareholders, investors, and all stakeholders.

The Company has established a “Company Handbook” as a practical framework covering key elements, including organizational culture (vision, mission, and core values), Code of Conduct, Code of Ethics for directors, executives, and employees, corporate governance principles, corporate social responsibility, and anti-corruption policy. All directors, executives, and employees are required to acknowledge, understand, and strictly comply with these guidelines, with ongoing monitoring and evaluation mechanisms in place.

In addition, the Company publishes the Company Handbook on its corporate website to ensure broad accessibility for stakeholders and conducts at least an annual review to align with legal developments, international standards, and evolving corporate governance practices.

Board Diversity

the Company places importance on Board Diversity, taking into account an appropriate composition that is aligned with the Company’s business strategy. This includes diversity in terms of professional skills, specialized expertise, experience, gender, age, and other qualifications beneficial to corporate governance. The Company remains open without restrictions based on race or nationality, and seeks to ensure that the Board consists of diverse members in order to strengthen governance perspectives and support balanced and effective strategic decision-making.

To ensure that such policy is clear and measurable, the Company has established the following quantitative targets and indicators relating to Board diversity:

  • The Company has set a target of having at least 3 female directors, or not less than 30% of the total number of directors.

  • The Company aims to ensure that the Board possesses a combination of skills, expertise, and experience covering key areas relevant to the Company’s operations, such as healthcare and medical services, business administration, finance and accounting, law, corporate governance, risk management, and sustainability.

  • The Company requires the Board Skill Matrix and Board composition to be reviewed at least once a year in order to assess the appropriateness of the Board structure in alignment with the Company’s strategy and organizational context.

In 2025, the Company made progress in implementing this policy and achieving the above targets. The Board of Directors consisted of 10 members, of whom 3 were female directors, representing 30% of the total Board, which is in line with the Company’s target. In addition, all 3 female directors served as independent directors, thereby strengthening independence and checks and balances in corporate governance.

At the same time, the Company reviewed the composition of the Board through the Board Skill Matrix approach to ensure that the Board possesses the knowledge, capabilities, and experience appropriate to the nature of the Company’s business and strategic direction. The Company considers that the current Board composition reflects an appropriate level of diversity and suitability that supports effective corporate governance.

The Company will continue to review and develop its Board structure on an ongoing basis in order to align with best practices for listed companies and to support the sustainable growth of the organization in the long term.

  • Nomination of Directors and Senior Executives

Although the Company does not have a dedicated nomination committee, the Board of Directors performs the duties of considering, nominating, and selecting qualified individuals for appointment as directors. The Board takes into account appropriate board composition, competencies aligned with the Company’s strategic direction, diversity, and independence.

  • Director Nomination Criteria

The Company prepares a Board Skill Matrix annually to guide director nominations, considering various nomination sources such as existing directors, shareholders, external advisors, and the Director Pool database of the Thai Institute of Directors (IOD).

  • Re-appointment of Directors

In considering the re-appointment of incumbent directors, the Board evaluates performance, meeting participation, and independence prior to proposing candidates for another term.

  • Appointment of Replacement Directors

In the event of a board vacancy prior to term completion, the Board will appoint a qualified individual in accordance with applicable laws, with approval by at least three-quarters of the remaining directors.

  • Shareholder Participation

The Company allows shareholders to nominate candidates for directorship in advance through the SET news system and the Company’s website during the period of 1 October – 31 December each year.

  • Board Independence from Management

The Company clearly separates the roles, duties, and responsibilities of the Board and management to ensure effective checks and balances. The Board is responsible for setting policies, vision, strategies, and monitoring performance, while management executes operations in accordance with the Board’s directives.

  • Director Development

The Company supports continuous development of directors and executives. The Company Secretary coordinates participation in training programs, seminars, and knowledge-sharing activities relevant to board responsibilities.

  • Remuneration Policy for Directors and Executives

Director and executive remuneration is aligned with the Company’s strategic objectives, responsibilities, and industry benchmarks to attract and retain qualified individuals. Director remuneration comprises:

  • Monetary compensation such as meeting allowances, gratuities, and bonuses; and

  • Non-monetary benefits such as healthcare benefits.

Executive remuneration is determined based on financial and non-financial KPIs, including sustainability performance, human resource management, and operational effectiveness.

  • Limitation on Directorships in Other Listed Companies

The Company limits directors from holding directorships in more than five listed companies to ensure sufficient time commitment.

In 2025, no director held directorships exceeding this limit.

  • Orientation for New Directors

The Company provides orientation programs for newly appointed directors, including business overview, organizational policies, legal frameworks, governance roles and responsibilities, and key corporate documents to support effective performance.

  • Performance Evaluation of the Board and Executives

Annual performance evaluations are conducted for the Board as a whole, individual directors, and board committees. Evaluation results are used to enhance governance effectiveness. The Board also evaluates the Chief Executive Officer annually, linking performance outcomes to remuneration and bonus considerations.

  • Disclosure and Transparency

The Company emphasizes accurate, adequate, and timely disclosure of information. Policies and charters have been reviewed and updated to align with international standards and regulatory requirements. During the past year, no regulatory reports regarding insider trading were received.

  • Investor Relations

The Company maintains an Investor Relations function reporting directly to the Chief Executive Officer, engaging in ongoing communication activities such as Analyst Meetings, Opportunity Day events, conference calls, and disclosures via the Company’s website.

In 2025, the Company held four Opportunity Day events.

  • Insider Information Governance and Securities Holding Reporting

The Company strictly enforces policies on insider information. Directors and executives are required to report changes in securities holdings within three business days and are prohibited from trading during the 30-day period prior to financial statement disclosure.

During the past year, no cases of insider trading were reported, and 100% of personnel acknowledged and complied with the policy.

Policy Document Link

https://investor.rph.co.th/th/corporate-governance/policies-and-guidelines

Policy & Practices — Board of Directors

Has Policy & Guidelines for the Board

Yes

Board Guidelines

GuidelineDetailDocument LinkPage Number in Report
Nomination of Directors

Criteria and Process for Nomination and Appointment of New Directors

The Board of Directors places strong emphasis on Board Effectiveness and Good Corporate Governance. The Company has therefore established a structured, transparent, and accountable nomination and appointment process to ensure that the Board composition remains appropriate and aligned with the Company’s strategic direction and long-term growth.When a Board vacancy arises, the Board of Directors undertakes a structured nomination process to identify candidates with suitable qualifications. Consideration is given to knowledge, professional experience, leadership capability, independence, industry expertise, and the ability to dedicate sufficient time to Board duties. All candidates must meet the qualifications required under applicable laws and relevant regulatory requirements.

The Company utilizes a Board Skill Matrix as a key governance tool to assess competency gaps and support skills-based governance. The matrix ensures that newly appointed directors possess expertise aligned with the Company’s business strategy, particularly during periods of expansion or new service development.

Board Diversity Policy

The Board of Directors recognizes the importance of board diversity as a key element in enhancing effective corporate governance. Diversity is considered across multiple dimensions, including gender, age, experience, expertise, and professional background, in order to promote balanced perspectives in strategic oversight and governance.

As of the reporting date, the Board of Directors comprises 10 members, of whom 3 are female directors, representing 30% of the total Board composition. This reflects the Company’s commitment to promoting gender balance and diversity at the Board level.

The Board conducts an annual review of its composition and structure, taking into account the Board Skill Matrix, the Company’s strategic direction, and diversity considerations, to ensure that the Board remains appropriately structured and capable of supporting effective oversight and sustainable business growth.

The Company does not impose restrictions based on gender, age, or background in the director nomination process. Instead, it promotes equal opportunity by encouraging the nomination of qualified candidates from diverse backgrounds to strengthen the Board’s capabilities and support long-term sustainable governance.

Transparent Director Sourcing

To promote transparency and fairness in the nomination process, the Company sources director candidates from multiple channels, including:

  • Recommendations from existing directors

  • Shareholder nominations

  • External advisory firms

  • The Director Pool of the Thai Institute of Directors Association (IOD)

Structured Nomination and Appointment Process

  • The Board of Directors oversees the nomination process and reviews candidate qualifications before proposing appointments to the shareholders’ meeting for approval by a majority vote.

  • Minority shareholders are given the opportunity to propose qualified candidates for Board election in advance, promoting shareholder participation and governance transparency.

  • The Board regularly reviews the Board Skill Matrix to ensure alignment between Board composition and the Company’s strategic direction.

  • In the case of mid-term vacancies, the appointment of a replacement director requires approval by at least three-quarters of the remaining directors.

Succession Planning Framework for Senior Executives

The Board of Directors has established a structured succession planning framework for the Chief Executive Officer and senior executives to ensure leadership continuity and mitigate risks arising from leadership transitions. Candidate selection considers experience, leadership capability, ethics, and strategic vision.

Appointment guidelines include:

  • The Board approves the appointment of the Chief Executive Officer.

  • The Chief Executive Officer approves appointments of executives and senior management.

  • The appointment of the Company Secretary requires Board approval.

  • The appointment of the Head of Internal Audit requires prior approval from the Audit Committee.

Leadership Development and Talent

The Company promotes sustainable leadership development through structured talent management and individual development plans. High-potential employees are assigned strategic responsibilities to build a strong leadership pipeline and support long-term organizational continuity.

Determination of Director Remuneration

Directors’ and Executives’ Remuneration

The Company establishes remuneration policies for directors and executives based on principles of appropriateness, transparency, and alignment with roles, responsibilities, and individual performance. The determination of remuneration takes into account the Company’s operating results, business size, growth prospects, and benchmarking against listed companies within the same industry to ensure competitiveness, fairness, and the promotion of sustainable value creation.

Such remuneration must be reviewed and approved by the shareholders’ meeting in accordance with good corporate governance principles to ensure transparency toward all stakeholders.

Directors’ Remuneration Policy

The Board of Directors determines the directors’ remuneration structure by considering the Company’s performance, business scale, scope of responsibilities, and benchmarking with peer listed companies in the same industry to ensure appropriateness and alignment with each director’s duties and responsibilities.

The remuneration structure is subject to approval by the shareholders’ meeting in compliance with applicable laws and corporate governance principles. The Company publicly discloses its directors’ remuneration policy and criteria on the Company’s website under the “Policies and Guidelines” section to ensure transparency and accessibility for shareholders and stakeholders.

Directors’ Remuneration Structure

The Company establishes a transparent and appropriate remuneration framework that aligns with directors’ roles, responsibilities, and the Company’s performance. Directors’ remuneration is divided into two categories: monetary compensation and non-monetary compensation, reflecting a balance between performance incentives and good corporate governance.

1) Monetary Compensation

Monetary compensation consists of:

  • Board of Directors’ and sub-committee meeting allowances

  • Directors’ remuneration (directors’ fees)

  • Annual bonus (equivalent to 2% of dividend payments)

The remuneration structure is determined based on the Company’s operating performance, business size, and the level of responsibility of each director’s position, with benchmarking against listed companies within the same industry to ensure appropriateness and competitiveness.

2) Non-Monetary Compensation

Non-monetary compensation includes welfare and benefits related to health and well-being that are appropriate to directors’ roles, such as medical benefits and annual health check-ups for directors and their families.

Both forms of remuneration are subject to consideration and approval by the shareholders’ meeting in accordance with good corporate governance principles to ensure transparency and fairness to all stakeholders.

https://investor.rph.co.th/storage/document/cg/policy-and-criteria-for-determining-directors-remuneration-th.pdf1-5
Independence of the Board of Directors from the Management

The Company has established an appropriate Board structure with a proportion of Independent Directors in accordance with regulatory requirements, enabling effective oversight, monitoring, and checks and balances against management. This structure enhances transparency, accountability, and independence in governance, thereby strengthening confidence among shareholders and all stakeholders.

In addition, the Company clearly defines the roles, duties, and responsibilities of the Board of Directors, which are segregated from the authority of day-to-day management functions. Such separation supports effective governance practices, mitigates potential conflicts of interest, and reinforces adherence to Good Corporate Governance principles.

The Company has publicly disclosed this policy on its website under the “Policies and Guidelines” section, specifically within the “Director Independence Policy,” to ensure transparency and accessibility for shareholders, investors, and stakeholders.

https://investor.rph.co.th/storage/document/cg/director-independence-policy-th.pdf1-6
Director Development

The Board of Directors places significant importance on the continuous development of directors, executives, and governance-level personnel to enhance their knowledge, competencies, and skills essential for effective corporate governance. This development supports the Company’s strategic direction and ensures alignment with evolving industry dynamics and business environments. The Company believes that systematic director development is a key element in strengthening governance effectiveness, fostering an ethical corporate culture, and enhancing confidence among shareholders, investors, and stakeholders.

Continuous Development of Directors and Executives

The Company encourages directors, sub-committee members, executives, and the Company Secretary to participate regularly in training programs, seminars, and knowledge-sharing activities, both internally and externally. These programs cover topics such as corporate governance, risk management, organizational strategy, sustainability governance, and capital market regulations to ensure that their roles are performed in accordance with international standards and regulatory expectations.

Such development initiatives are conducted through internal programs as well as courses offered by external institutions, including the Thai Institute of Directors Association (IOD) and the Stock Exchange of Thailand (SET). The Company Secretary coordinates and monitors directors’ participation in these development activities on an ongoing basis.

Director Orientation Program

The Company arranges an orientation program for all newly appointed directors to provide a comprehensive understanding of the Company’s business structure, vision, strategy, legal responsibilities, corporate governance policies, and code of conduct. The Company Secretary facilitates this process by preparing key information and supporting directors to perform their duties effectively from the outset.

Corporate Governance Development Framework for Directors

The Company promotes director development across multiple levels to strengthen governance capabilities, including:

  • Foundation Level: such as Director Accreditation Program (DAP) and corporate governance courses

  • Committee Level: programs designed for Chairmen, Audit Committee members, and other board committees

  • Functional Level: including Finance for Directors, Strategy Formulation, Strategy Measurement, Risk Planning, and Chartered Director programs

In 2025, the Company implemented a structured development plan, including the Director Accreditation Program (DAP) for newly appointed directors to strengthen their understanding of governance roles and responsibilities.

Training and Seminar Participation

During 2025, directors attended various training programs and seminars organized by the Thai Institute of Directors Association (IOD) and the Stock Exchange of Thailand (SET) to enhance their governance knowledge and apply best practices to the Company’s oversight framework on a continuous basis.

Board Performance Evaluation

Performance evaluation of the Board of Directors and subcommittees

The Company arranges for a self-evaluation of the Board of Directors and subcommittees related to good corporate governance according to the Board self-evaluation form issued by the Stock Exchange of Thailand. The evaluation forms are conducted for both the Board and individuals at least once a year. The Board of Directors jointly determines the criteria for evaluating their own performance, both as a Board and as an individual. Self-evaluations are required to be conducted annually, and the Board of Directors jointly considers the evaluation results to determine guidelines for improving the work in the future.

1. Board of Directors Evaluation Form

The evaluation form for the entire Board of Directors consists of 4 topics:

1) Structure and qualifications of the Board

2) Board meetings

3) Roles, duties and responsibilities of the Board

4) Other matters

The evaluation form for the individual Board of Directors consists of 3 topics:

1) Structure and qualifications of the Board

2) Board meetings

3) Roles, duties and responsibilities of the Board


2. Subcommittee Evaluation Form

Subcommittee Evaluation Form Consists of 3 topics:

1) Structure and qualifications of the board

2) Board meetings

3) Roles, duties, and responsibilities of subcommittees In terms of the assessment form of the audit committee, the assessment form according to the SEC's audit committee manual has been adapted, adding a section on the overall duties of the audit committee and the specific duties of the audit committee.

The assessment of individual subcommittees consists of 3 topics:

1) Structure and qualifications of the board

2) Roles, duties, and responsibilities of subcommittees

3) Board meetings

Corporate Governance of Subsidiaries and Associated Companies

Governance of Subsidiaries and Associates

Ratchaphruek Hospital Public Company Limited (the “Company”) places strong emphasis on the effective governance of its subsidiaries and associates. The Company has established a Subsidiary and Associate Governance Policy as a framework to ensure systematic, transparent, and accountable management and oversight through both direct and indirect mechanisms.

The objective of this policy is to enable the Company to supervise and manage the operations of its subsidiaries and associates in alignment with the Company’s strategic direction and principles of good corporate governance, as if they were integral parts of the organization. The governance framework encompasses policy alignment, risk management, internal control systems, and regular performance monitoring and reporting.

All subsidiaries and associates are required to operate in compliance with applicable laws and regulations, including the Public Limited Companies Act, the Civil and Commercial Code, the Securities and Exchange laws, as well as relevant rules, notifications, and guidelines issued by the Capital Market Supervisory Board, the Securities and Exchange Commission, and the Stock Exchange of Thailand. This approach aims to safeguard the Company’s investment interests while strengthening confidence among shareholders and stakeholders over the long term.

https://investor.rph.co.th/th/corporate-governance/policies-and-guidelines1-6

Policy & Practices — Shareholders and Stakeholders

Has Policy & Guidelines for Shareholders and Stakeholders

Yes

Shareholder & Stakeholder Guidelines

GuidelineDetailDocument Link
Shareholder

Policies and Practices Relating to Shareholders and Stakeholders

Equal Treatment of Shareholders

Ratchaphruek Hospital Public Company Limited (“the Company”) adheres to the principles of good corporate governance by ensuring that all shareholders are treated fairly, equitably, and transparently. The Board of Directors has established clear policies and practices to prevent discrimination and to avoid any actions that may create unfair advantages between major and minority shareholders.

The Company operates with a commitment to safeguarding shareholders’ rights as owners of the business while promoting long-term value creation for shareholders and all stakeholders under the principles of transparency, accountability, and fair disclosure.

Disclosure of Information and Equal Access to Information

The Company ensures that material information is disclosed accurately, sufficiently, and in a timely manner through the Stock Exchange of Thailand’s information system, the Company’s website, and investor relations channels, allowing shareholders to access information equally.

The Company has implemented strict practices regarding:

  • Disclosure of material information

  • Securities trading blackout periods

  • Related-party transaction controls

  • Disclosure of directors’ and executives’ shareholdings

  • Management of conflicts of interest

In 2025, the Company did not identify any material conflict-of-interest cases.

Insider Trading Prevention

The Company has established a policy prohibiting the use of inside information for personal gain and requires directors, executives, medical personnel, and employees to strictly maintain confidentiality. The policy is communicated through the Company’s Intranet and RPH Staff platforms, with a mandatory acknowledgement system.

As of 31 December 2025, 100% of personnel acknowledged and complied with the policy. The Company received no regulatory warnings or penalties relating to insider trading during the year.

Enhancement of Shareholder Rights

The Company promotes active shareholder participation in corporate governance through transparent shareholder meeting processes aligned with CGR and AGM Checklist best practices, as follows:

Before the Shareholders’ Meeting

  • Shareholders are invited to propose agenda items and nominate director candidates in advance.

  • The meeting date was disclosed 64 days in advance.

  • The meeting invitation in Thai and English was published 46 days prior to the meeting.

  • Proxy Forms A, B, and C were provided, including independent directors as proxy options.

  • Information was disclosed via the Company’s website and SET channels on an equitable basis.

During the Meeting

  • Online registration opened more than two hours prior to the meeting.

  • The Company Secretary explained shareholders’ rights and voting procedures.

  • An ETDA-certified e-AGM system was utilized.

  • A legal advisor oversaw compliance with applicable laws and regulations.

  • No additional agenda items were introduced beyond those stated in the notice of meeting.

  • Shareholders were given equal opportunities to ask questions and express opinions, with the Chairman, Audit Committee Chairman, Chief Executive Officer, finance executives, and auditors present to respond.

After the Meeting

  • Meeting resolutions and voting results were submitted to the SET on the meeting date.

  • The minutes of the meeting in Thai and English were disclosed within 14 days.

The Company held the 2024 Annual General Meeting of Shareholders on 23 April 2025 via electronic means to enhance accessibility for all shareholders.

Governance Perspective on Shareholder Rights (CGR Perspective)

The Board of Directors places strong emphasis on protecting shareholders’ rights in accordance with the Corporate Governance Code of the Stock Exchange of Thailand. The Company promotes transparency, equitable treatment, and meaningful shareholder participation through robust disclosure practices, effective shareholder meeting processes, strict insider trading controls, and comprehensive conflict-of-interest management. These mechanisms are fundamental to strengthening investor confidence and supporting the Company’s sustainable growth.

https://investor.rph.co.th/th/document/shareholder-meetings?year=2024
Employee

Employee Treatment

The Board of Directors recognizes that employees are valuable resources and a key driver of the Company’s long-term success and sustainable growth. Accordingly, the Company has established human resource management policies and practices based on fairness, equality, and respect for human rights, as follows:

  • Treat employees with respect for human dignity and fundamental labor rights, while ensuring appropriate protection of employee confidentiality and personal data.

  • Manage human resources in compliance with labor laws, the Company’s work regulations, and principles of good corporate governance.

  • Promote equality and non-discrimination, without bias on the basis of gender, age, race, religion, disability, or any other status unrelated to job performance.

  • Support continuous learning and capability development to enhance employee potential, career stability, and opportunities for professional growth.

  • Encourage employee participation in organizational development and provide fair communication channels for suggestions, feedback, and grievance handling.

  • Establish a fair and competitive remuneration and welfare structure aligned with performance, including healthcare benefits and provident fund arrangements.

  • Provide a safe working environment and necessary facilities with due consideration to occupational health, safety, and employees’ quality of life.

  • Promote employee participation in the Company’s social and environmental responsibility activities.

Based on these principles, the Company places strong emphasis on systematic human resource management and continuous talent development, as disclosed in the Annual Report (Form 56-1 One Report) under the section relating to directors, executives, and employees.

In 2025, no employee complaints were received.

Customer

The Company’s Board of Directors recognizes that customer satisfaction and trust are key to the Company’s long-term success. Therefore, the Company has established policies and practices to uphold these principles.

1) The Company conducts its medical and healthcare business with quality and safety, guided by the ethics of professional integrity.

2) The Company is committed to improving healthcare capabilities for increasingly complex diseases. It considers sourcing modern medical tools, as well as developing an electronic medical record system for fast, accurate, and reliable access to information. This system ensures continuous service that meets the needs of clients and patients, while also providing sufficient information to aid in decision-making without withholding or distorting facts.

3) The Company operates with integrity, fairness, and honesty, and does not engage in any actions that would violate the rights of patients. It protects patient confidentiality and does not use confidential information for personal gain or allow others to do so.

4) The Company does not solicit, accept, or agree to accept any illicit gifts or benefits from patients, either directly or indirectly.

5) The Company provides excellent service, focusing on patient satisfaction by minimizing waiting times. If this cannot be achieved, patients are informed in advance, and alternative solutions are found to prevent undue delays or harm.

6) The Company has established communication channels for patients to file complaints, make suggestions, or provide feedback. All complaints are addressed promptly and handled fairly.

Based on these policies and practices, the Company has taken these actions. The Board of Directors acknowledges that customer satisfaction and trust are essential to the Company’s sustainable success. The Company follows policies on environmental quality, safety, energy conservation, social responsibility, and anti-corruption.

Additionally, the Company communicates with customers, patients, and service users through mobile notifications and maintains contact channels where clients can provide feedback and assess the quality of service for both outpatient and inpatient groups. This helps ensure that all feedback is valued, with a direct line to the CEO’s office available at every point within the hospital.

In 2024, the Company had one legal dispute with a patient involving a consumer rights case.

However, there are no other significant legal disputes that could impact the Company’s operations. Other complaints are analyzed for causes, and corrective actions are taken to prevent recurrence across the organization.

Business competitor

The Company’s Board of Directors operates the business in accordance with legal provisions and has set these policies and practices.

1) Operate within the framework of fair competition, considering business ethics and the competition laws in the countries where the Company operates.

2) Avoid damaging the reputation of competitors.

3) Do not solicit employees from competitors. Based on these policies and practices, the Company has implemented these actions.

- Any business dealings with competitors must be conducted within the framework of fair competition.

- The Company views competitors as an integral part of strengthening the organization's capabilities, making it more stable and robust.

- The Company does not seek confidential information from competitors through inappropriate means.

In 2024, the Company had no disputes with any competitors.

Business partner

1) Policy and Practices

The Board of Directors treats business partners with fairness and equity, taking into account mutual benefits, and has established policies and guidelines governing business relationships with suppliers and partners. In accordance with such policies and practices, the Company has implemented the following measures.

  • The Company strictly complies with agreed commercial terms and conditions, provides accurate and transparent information, and fosters constructive relationships and mutual understanding with its suppliers, including knowledge exchange to jointly enhance medical services. The Company does not solicit, accept, or consent to receive any assets or benefits beyond the agreed commercial arrangements. Accordingly, the Company has established a Supplier Code of Conduct and implemented procurement processes in line with quality management systems, environmental management systems, and occupational health and safety management standards. In addition, the Company has formulated procurement regulations to serve as operational guidelines for conducting business with suppliers in an efficient, appropriate, and fair manner, in accordance with the principles of good corporate governance.

  • The Company recognizes its responsibilities toward society and the environment and encourages suppliers to develop their operational processes with due regard to human rights, fair labor practices, the prohibition of forced labor, respect for children’s rights, occupational health and safety, and environmental management. Suppliers are also encouraged to offer products and services that take into account environmental and safety impacts, continuously improve work processes to prevent pollution, mitigate environmental impacts, conserve natural resources, reduce excessive energy consumption, and eliminate occupational safety risks.

  • The supplier selection and evaluation criteria, as well as procurement processes, are considered critical to cost management and product quality for the Company’s optimal benefit. The Company selects suppliers based on their ability to meet production and service requirements, product quality standards, production capacity, compliance with relevant management system standards, service readiness, logistics capabilities, occupational health and safety performance, and overall business practices that demonstrate responsibility toward society and the environment.

2) Action Plans and Implementation Guidelines

To ensure that supplier capacity development is implemented in a concrete and effective manner, the Company has continuously carried out action plans and activities, including:

  • Communicating the Company’s policies, standards, and expectations regarding quality, safety, and business ethics to suppliers;

  • Organizing knowledge-sharing activities, joint meetings, or training sessions with suppliers and partners on matters related to the development of medical services, healthcare technologies, and patient care; and

  • Collaborating with suppliers in the development of health-related activities, proactive healthcare services, and social activities conducted jointly by the Hospital and its partner network.

3) Performance and Outcomes

  • As a result of the implementation of the above policies, the Company has been able to continuously strengthen collaboration with suppliers and business partners. This has led to improved supplier understanding of the Company’s operational standards and service approaches, more consistent quality of products and services related to medical care, and effective support for health-related activities and patient services.

  • Furthermore, such collaboration has contributed to the mitigation of operational risks and enhanced the Company’s image as a healthcare organization that prioritizes quality, safety, and sustainable growth together with its suppliers and the community.

Green and Safe Supplier Promotion

Implementation Approach and Key Actions

The Hospital considers and communicates environmental, safety, and occupational health guidelines to its suppliers, as appropriate. Key areas include the reduction of unnecessary packaging, proper waste management in accordance with environmental principles, and compliance with occupational safety standards, in support of responsible procurement practices.

Performance Results and Outcomes

  • Suppliers demonstrate greater awareness and improvement in their environmental and safety practices.

  • Environmental and safety risks associated with procurement processes are mitigated.

  • The Hospital’s image as a responsible and sustainable healthcare organization is reinforced.

Collaborative Health Promotion and CSR Activities

Implementation Approach and Key Actions

The Hospital collaborates with suppliers and partners in organizing health promotion and social activities, such as support for emergency medical response, blood glucose management and education, stroke prevention and care, as well as proactive healthcare services and community health promotion activities.

Performance Results and Outcomes

  • Access to healthcare services for the public and local communities is enhanced.

  • Stronger relationships and long-term collaboration with suppliers are fostered.

  • The role of the Hospital and its suppliers in jointly creating social value is clearly demonstrated.

4) Evaluation and Assessment Results

The Procurement Department conducts evaluations of new suppliers and service providers prior to entering into procurement or service arrangements, as well as annual evaluations of existing suppliers listed in the Approved Vendor List, which are assessed at least once per year. In addition, the Company is in the process of developing key performance indicators and monitoring systems to further enhance supplier relationship management over the long term.

Creditor

The Board of Directors upholds a principled and disciplined approach to business operations to build trust with creditors. This commitment is reflected in these policies and practices.

1) Treat all creditor groups equally and fairly.

2) Strictly adhere to all agreements and contractual obligations.

3) Manage operations to ensure creditors’ confidence in the Company’s financial stability and debt repayment capability.

4) Disclose financial status accurately and in a timely manner.

5) In cases where compliance with any contractual condition is not possible, promptly notify creditors in advance to collaboratively find solutions and prevent potential damages.

In alignment with these policies and practices, the Company has consistently met its obligations to creditors and has conducted regular performance analysis and monitoring. This proactive approach ensures financial stability and repayment capability while mitigating risks related to guarantees, in accordance with fair and ethical competition practices within legal frameworks.

In 2025, there were no disputes with creditors.

Government agency

The Board of Directors conducts business in full compliance with government regulations and has established these policies and practices.

1) Study and understand all relevant laws and refrain from any actions that violate legal provisions.

2) Conduct transactions with government officials and agencies in a lawful and proper manner.

3) Maintain a positive relationship with government entities within appropriate boundaries.

4) Adhere to the laws, customs, and traditions governing business operations in each country or locality.

In alignment with these policies, the Company ensures compliance with all regulations set by governing bodies, including the Stock Exchange of Thailand, the Securities and Exchange Commission, and other relevant government agencies.

The Company believes that supporting regulatory development contributes to the long-term sustainability of the healthcare industry, enhancing Thailand’s competitiveness in medical and public health sectors. As part of its corporate social responsibility, the Company actively participates in policy and regulatory development efforts to promote sustainable progress.

The Company regularly engages with industry and trade organizations, such as the Khon Kaen Chamber of Commerce, the Federation of Thai Industries, the Thai Listed Companies Association, and the Thai Institute of Directors Association, through membership support and participation in various activities.

In 2025, the Company did not provide financial support for political campaigns or political organizations and remained politically neutral. Any political contributions, whether monetary or in assets, must be transparent and comply with the Company’s anti-corruption policy.

Community and society

The Board of Directors conducts business with a strong sense of duty and responsibility toward the nation, communities, and society while respecting local customs and traditions. The Company is committed to maintaining a positive social environment and has established policies and practices to support this commitment.

1) Refrain from engaging in business activities that negatively impact society or violate the rights of individuals within the community.

2) Instill a continuous awareness of social and community responsibility at all levels of the Company and among employees.

3) Implement measures to prevent and mitigate any negative impact of the Company’s operations on communities and society.

4) Promote the preservation of local culture, customs, and traditions.

5) Collaborate with various organizations to support community development.

6) Provide support for activities that contribute to public welfare.

7) Generate income and support local economies by promoting employment and community-based products.

8) Foster positive relationships between the Company and the community based on integrity, transparency, and fairness.

In 2024, there were no legal disputes between the Company and the community, nor were there any significant complaints from the community. Other complaints received were analyzed to determine their causes, with corrective and preventive actions implemented across the organization to ensure continuous improvement and prevent future issues.

Code of Conduct

Sub-Section Introduction

Has a Business Code of Conduct

Yes

Code of Conduct Description

Business Ethics and Ethical Culture

The Board of Directors places significant importance on fostering an organizational culture grounded in ethics, transparency, and accountability toward all stakeholders. Business ethics are regarded as a fundamental component of good corporate governance and an integral part of the Company’s sustainable growth strategy.

The Board has established and regularly reviewed the Code of Conduct, along with related policies such as the Anti-Corruption Policy, Conflict of Interest Policy, Insider Trading Prevention Policy, and Personal Data Protection Policy. These policies are incorporated into the Company Handbook, which serves as a practical guideline for directors, executives, medical professionals, and employees at all levels.

Ethics Implementation

The Company integrates business ethics into its operational processes and decision-making at all levels through the following key practices:

  • Promoting a strong “Tone from the Top”, whereby the Board of Directors and management lead by example in ethical conduct

  • Providing regular training on ethics, anti-corruption practices, and insider trading prevention

  • Integrating ethical considerations into risk management and internal control processes

  • Establishing clear guidelines on gift-giving, business dealings with partners, and conflict-of-interest prevention

  • Encouraging ethical medical practices, transparency, and patient safety as core principles of healthcare services

Whistleblowing Mechanism and Protection

The Company provides confidential and secure channels for reporting concerns or potential misconduct. Appropriate whistleblower protection measures are in place, and all reports are reviewed through a transparent process under the oversight of relevant Board committees.

Ethics Monitoring and Governance KPIs

To ensure effective implementation of ethical practices, the Company has established Governance KPIs, including:

  • Ethics Training Completion: 100%

  • Ethical Culture Score ≥ 80%

  • Whistleblowing Response ≥ 95%

  • No Insider Trading Case

These indicators reflect the Company’s commitment to maintaining a transparent and responsible ethical culture.

Ethical Culture Outcomes

In 2025, the Company communicated and provided ethics-related training through the RPH Staff system and the Company’s intranet, supported by a digital acknowledgment process. All directors, executives, employees, and medical personnel confirmed their acknowledgment and commitment to comply with the policies, achieving a 100% participation rate.

During the reporting period, the Company did not receive any regulatory warning letters and no cases of insider trading misconduct were identified, demonstrating the Company’s continued adherence to ethical business practices.

1. Responsibilities Toward Stakeholders

The Board of Directors encourages collaboration with all stakeholder groups to create shared value and sustainable growth. The Company’s stakeholders include shareholders, patients/customers, business partners, competitors, creditors, employees, communities, society, the environment, and government authorities.

The Board performs its duties with prudence, integrity, and accountability, aiming to deliver sustainable returns to shareholders through the following practices:

  • Respect shareholder rights and ensure equitable and fair treatment.

  • Operate in accordance with good corporate governance principles to build investor confidence.

  • Continuously develop the business to achieve sustainable growth and appropriate returns.

  • Disclose material information accurately, transparently, and in a timely manner.

  • Include the Board of Directors’ Responsibility Statement on financial reports in the annual report.

  • Provide minority shareholders opportunities to propose agenda items or nominate directors.

  • Allow shareholders to submit questions in advance of shareholders’ meetings.

  • Publish the notice of shareholders’ meetings on the Company’s website at least 30 days in advance in both Thai and English.

  • Facilitate shareholders’ participation, including proxy voting arrangements.

  • Manage conflicts of interest carefully with transparency and full disclosure.

  • Safeguard the Company’s assets with the same care as a prudent person would exercise over their own property.

1.2 Patients / Service Recipients / Customers

The Company recognizes that patient satisfaction and trust are key drivers of sustainable success and has established the following practices:

  • Deliver medical services with quality, safety, and professional ethics.

  • Continuously enhance medical capabilities, modern medical equipment, and electronic medical record systems.

  • Provide accurate, sufficient, and transparent treatment information to support informed decision-making.

  • Maintain strict confidentiality of patient information.

  • Prohibit solicitation or acceptance of improper benefits from patients.

  • Deliver patient-centric services aimed at minimizing waiting times and enhancing service quality.

  • Provide communication channels for complaints and feedback, ensuring fair and appropriate handling.

1.3 Business Partners

The Company treats business partners fairly and transparently while emphasizing mutual benefits through:

  • Compliance with contractual agreements and fostering long-term collaboration.

  • Establishment of a Supplier Code of Conduct and transparent procurement procedures.

  • Encouraging partners to operate responsibly with respect to human rights, labor practices, environmental management, and safety standards.

  • Applying supplier selection criteria based on quality standards, service readiness, occupational health and safety, and sustainability practices.

1.4 Competitors

The Company conducts business under fair competition principles by:

  • Complying with applicable competition laws and ethical business practices.

  • Avoiding actions that damage competitors’ reputations.

  • Refraining from unfair recruitment or unethical competitive behavior.

1.5 Creditors

The Company aims to maintain strong relationships with creditors through:

  • Fair and equitable treatment of all creditor groups.

  • Strict compliance with contractual terms and obligations.

  • Maintaining financial discipline to ensure debt repayment capability.

  • Providing accurate and timely financial disclosures.

  • Promptly notifying creditors when the Company anticipates any inability to meet contractual conditions.

1.6 Employees

The Company recognizes employees as valuable resources and key contributors to organizational success. The Company therefore:

  • Respects human dignity and fundamental labor rights.

  • Promotes equality and non-discrimination.

  • Supports continuous learning, career development, and knowledge sharing.

  • Provides fair compensation and appropriate welfare benefits.

  • Encourages employee participation and open communication channels.

  • Maintains a safe and healthy working environment to enhance quality of life.

1.7 Community and Society

The Company operates with responsibility toward society by:

  • Avoiding business practices that harm society or violate community rights.

  • Promoting social responsibility awareness among employees.

  • Supporting public benefit initiatives and community development programs.

  • Building transparent and constructive relationships with local communities.

1.8 Environment

The Company conducts its business with environmental responsibility through:

  • Compliance with environmental laws, regulations, and policies.

  • Promoting efficient and sustainable use of resources.

  • Developing environmental management systems and continuous monitoring practices.

  • Selecting supply chain partners that demonstrate environmentally responsible practices.

1.9 Government Sector

The Company conducts business with integrity and in compliance with government regulations by:

  • Studying and complying with all relevant laws and regulatory requirements.

  • Conducting transactions with government officials transparently and appropriately.

  • Maintaining constructive relationships with government agencies within appropriate boundaries.

  • Respecting applicable laws, customs, and traditions in each operating jurisdiction.

Code of Conduct Practices

GuidelineDetailDocument LinkPage Number in Report
Prevention of Misuse of Inside Information

Conflict of Interest Policy

The Board of Directors has established policies and guidelines for managing conflicts of interest to ensure transparency, fairness, and the best interests of the Company, as follows:

  1. The Company shall carefully and fairly consider conflicts of interest and connected transactions through a transparent approval process, taking into account the Company’s best interests. Directors with vested interests shall abstain from voting, and full disclosure shall be made in accordance with the regulations of the Securities and Exchange Commission and the Stock Exchange of Thailand.

  2. All directors, executives, and employees shall act in the best interests of the Company and in compliance with applicable laws, refraining from any actions that may create conflicts of interest or provide undue benefits or privileges to any person.

  3. Directors and executives are required to disclose their interests and those of related persons in accordance with the prescribed criteria and procedures.

  4. Directors, executives, and employees who have access to inside information are prohibited from trading the Company’s securities during the period of one month prior to the public disclosure of the financial statements and until 24 hours after such disclosure.

  5. Directors, executives, including their spouses and minor children, are required to report their shareholdings and any changes in shareholdings in the Company to the Securities and Exchange Commission and notify the Company Secretary accordingly.

  6. Confidential information or trade secrets of the Company must not be disclosed or communicated to external parties or unauthorized persons.

  7. Disclosure of Company information shall be made only by authorized personnel. The Company may classify information according to confidentiality levels, and disclosure must be conducted within the scope of assigned duties and responsibilities.

  8. Directors and senior executives are required to notify the Chairman of the Board or the Company Secretary at least one day in advance prior to trading the Company’s shares.

In 2025, the Company did not receive any complaints relating to conflicts of interest.

https://investor.rph.co.th/storage/document/cg/connected-transaction-policy-th.pdf1-12
Anti-corruption

The Board of Directors places significant importance on compliance with applicable laws and good corporate governance principles. The Company has established an Anti-Corruption and Anti-Bribery Policy to serve as a framework for conducting business with transparency, fairness, and accountability. The key practices are as follows:

  1. Promote awareness, values, and positive attitudes among employees to ensure compliance with laws, regulations, and ethical standards, with integrity and honesty in performing their duties.

  2. Establish an effective internal control system, including appropriate checks and balances, to prevent fraud, misconduct, and involvement in any form of corruption.

  3. Directors, executives, and employees are strictly prohibited from soliciting, accepting, or agreeing to accept any assets or benefits, directly or indirectly, for themselves or others, which may influence improper performance of duties or cause damage to the Company’s legitimate interests.

  4. Directors, executives, and employees are prohibited from offering or giving any assets or benefits to external parties to induce unlawful actions or actions inconsistent with their duties and responsibilities.

  5. Maintain transparent, accurate, and reliable financial reporting mechanisms.

  6. Establish communication channels that allow employees and stakeholders to report suspicious activities or potential misconduct with confidence that whistleblowers will be protected. Designated personnel shall be responsible for investigating all reported matters.

Implementation of the Policy

In accordance with the above policy and practices, the Company has undertaken the following actions:

  1. The Board of Directors has reviewed and approved the Anti-Corruption and Anti-Bribery Policy and established an Anti-Corruption Manual as practical guidelines for directors, executives, and employees at all levels. The policy emphasizes prevention and opposition to all forms of corruption, both direct and indirect, and strictly prohibits involvement in bribery or corrupt practices with government or private sector entities to gain unfair competitive advantages. Clear guidelines have also been established for activities that may pose corruption risks. The policy has been formally announced within the organization and communicated to all directors, executives, and employees for strict compliance.

  2. Following the policy approval, management was assigned to communicate and disseminate the policy to employees throughout the organization via the Company’s internal communication channels. Acknowledgment of the policy has been completed by 100% of employees.

In 2025, the Company did not receive any complaints relating to fraud or corruption.

https://investor.rph.co.th/th/corporate-governance/anti-corruption-and-anti-bribery1-10
Whistleblowing and Protection of Whistleblowers

The Company conducts its business with transparency and recognizes the importance of preventing corruption, bribery, and all forms of misconduct. The Company is committed to operating in compliance with applicable laws and in a manner that benefits society, while encouraging employees to perform their duties with integrity and to act as responsible corporate citizens.

The Board of Directors provides channels for employees and stakeholders to report whistleblowing information or submit complaints in cases where suspected violations of laws, fraud, misconduct, or inappropriate behavior by employees are identified, including any actions that may cause damage to the Company. The Company also accepts complaints from employees and stakeholders who believe that their rights have been violated or that they have not received fair treatment, through the channels and procedures established by the Company.

The Company treats all complaints equally, transparently, and fairly. A systematic and fair whistleblower protection mechanism is in place, and all information relating to whistleblowers is kept strictly confidential. The Company’s whistleblower protection measures include the following:

1) Whistleblowers may choose to remain anonymous if disclosure of their identity may result in safety risks or potential harm.

2) The Company maintains confidentiality of all relevant information and prioritizes the safety of whistleblowers. Employees and individuals who cooperate in fact-finding processes are protected from unfair treatment resulting from the submission of complaints, such as workplace harassment, reassignment, or termination of employment.

In 2025, the Company did not receive any whistleblowing reports or complaints. The Company has disclosed its whistleblowing policy and procedures on the Company’s website under the Investor Relations section, including the reporting channels and the whistleblowing policy.

Interpretation and Guidance

Supervisors are responsible for providing guidance to their subordinates to ensure understanding and compliance with the Company’s Code of Conduct. In cases where the Code of Conduct does not cover specific situations, or where employees remain uncertain about how to proceed or make decisions, they are required to consult their supervisors in accordance with the established chain of command. In the event of disputes or conflicting interpretations, the decision of the Chief Executive Officer or the Board of Directors shall be deemed final.

https://investor.rph.co.th/storage/document/cg/whistle-blowing-policy-th.pdf1-10
Preventing the Misuse of Inside Information

The Company has a policy on the management of insider information, which is outlined in the business ethics code that applies to the Company and its shareholders. This is also included in the employee code of conduct. The Company mandates that its Board of Directors, executives, and employees perform their duties with honesty, responsibility, discipline, and a sense of good public and personal conscience. They are prohibited from using their positions to gain benefits for themselves and/or others inappropriately. They must protect the interests and assets of the Company and not use the Company’s information or assets for personal benefit and/or the benefit of others. They are also prohibited from supporting others in engaging in business that competes with the Company. The Company oversees the use of insider information in line with good corporate governance principles, and this is documented and published on the Company’s Intranet system and website. This includes the business ethics code for directors, executives, and employees, as well as the manual on the roles, duties, and responsibilities of directors, executives, and employees.

The Company also has a policy manual on anti-corruption measures, which is provided to directors, executives, and employees upon their hiring. The key policies are summarized as follows;

(1) The Company requires that the directors, executives, and employees sign an acknowledgment of the announcements from the Securities and Exchange Commission (SEC), which stipulate that directors and executives must report changes in their securities holdings to the SEC under Section 59 of the Securities and Exchange Act, B.E. 2535, within 3 days. This must be done via the electronic information exchange system as prescribed by the SEC, in accordance with the SEC's announcement (SEC Notification No. 38/2561) on the reporting of changes in securities holdings and futures contracts by directors, executives, auditors, and plan administrators, dated July 16, 2018 ("SEC Notification No. 38/2561"). They must also notify the Company Secretary to record and summarize the changes in the securities holdings of directors and executives individually for presentation to the Board of Directors in the next meeting. Additionally, the Company has informed of penalties for any violations or non-compliance with these requirements.

(2) The Company has regulations prohibiting the disclosure of financial statements or any information that may affect the Company's stock price to external parties or those not involved. Additionally, it prohibits trading in the Company’s securities within one month before the financial statements or any information that may affect the stock price is publicly released. Trading in the Company’s securities must not occur until 24 hours after such information has been fully disclosed to the public. Failure to comply with these regulations is considered a violation of the Company's discipline. Directors, executives, or employees who acquire significant insider information and violate the rules will face penalties, ranging from warnings, wage deductions, suspension without pay, to dismissal. This approach has been approved by the Board of Directors.

(3) The Company has a policy that requires directors and executives to notify the Board of Directors and/or the Company Secretary at least one day in advance before making any purchases or sales of the Company’s shares.

(4) The Company has implemented measures to manage conflicts of interest for its directors and executives. Directors and executives must report their personal interests and the interests of related parties that may impact the management of the Company, according to the guidelines set by the Company.

(5) The Company has also developed a system to control the use of insider information by utilizing information technology systems to define access levels to insider information according to the duties and responsibilities of each employee. Each employee has a personal password to access the system.

In 2025, the directors and executives of the Company strictly adhered to the policies, and there was no record of share trading during the restricted period. They did not receive any warnings or disciplinary actions related to securities trading violations from the SEC.

https://investor.rph.co.th/storage/document/cg/securities-trading-policy-of-directors-executives-and-employees-and-subsidiaries-th.pdf1-10
Giving or receiving gifts, entertainment, or business entertainment

Ratchaphruek Hospital Public Company Limited is committed to conducting its business with integrity, transparency, fairness, and equal treatment of all stakeholders.

To prevent conflicts of interest and promote ethical business practices, the Company has established guidelines regarding the giving and receiving of gifts, vouchers, benefits, and hospitality as follows:

1) Executives and employees must not solicit, accept, or agree to accept any gifts, vouchers, or other benefits from customers, business partners, or related persons with the intent to influence business decisions, induce improper actions, or omit required duties. In circumstances where refusal is impractical, personnel must strictly comply with the Company’s prescribed regulations.

2) The giving or receiving of gifts, vouchers, or any other benefits must not involve illegal items or activities that violate applicable laws or regulations.

3) Executives and employees are required to report to their respective supervisors any giving or receiving of gifts, vouchers, or benefits with a customary value exceeding Baht 3,000. Where the supervisor determines that such gifts may influence decision-making or lead to inappropriate conduct, the employee may be required to decline, return, or submit the gift to the Company as common property.

4) Any gifts, benefits, or hospitality provided to customers or related persons must be supported by proper expense documentation clearly indicating the value and purpose of such hospitality for audit and transparency purposes.

In 2025, the Company did not receive any complaints relating to the solicitation, acceptance, or offering of gifts or benefits that may have influenced business decisions.

Use and maintenance of data and assets

Protection and Maintenance of Company Assets

Directors, executives, and employees have a duty and responsibility to ensure the efficient use and safeguarding of the Company’s assets and those under its management. To support this, the Company has put in place clear guidelines for proper asset management.

1) Use Company assets solely for business purposes and do not exploit them for personal gain or for the benefit of external parties.

2) Protect Company assets from loss, damage, or misuse, exercising the same level of care as a prudent individual would with their own property, while preventing any improper personal gain.

3) Ensure adequate insurance coverage to protect Company assets against potential damages.

4) Do not use computers to access others’ systems or data protected by security measures, intercept computer data, damage, destroy, alter, or disrupt another person’s information in violation of computer crime laws. The Company must maintain IT security measures in accordance with international standards.

5) Use Company-provided email and internet services responsibly for business purposes, ensuring that usage does not harm the Company’s reputation.

6) Keep login credentials for accessing Company IT systems confidential and do not allow others to use them.

7) Do not reproduce, modify, or otherwise use the Company’s intellectual property for personal or third-party benefit without proper authorization.

8) Report to supervisors upon witnessing actions that violate rights, or may lead to rights violations or actions that could result in disputes related to the Company's intellectual property.

9) Ensure that important Company documents are stored and maintained for the legally required period. Once the retention period has expired, responsible employees must oversee the appropriate disposal of such documents.

Cyber security

Information Technology Security Policy

In order to establish appropriate guidelines for the use of information and information technology systems of Ratchaphruek Hospital Public Company Limited and its subsidiaries that share common systems, ensuring security, reliability, and continuity in supporting the Company’s operations, and to ensure compliance with the Computer Crime Act and other applicable laws, as well as to prevent potential threats that may cause damage to the Company, the Company has established the Information Technology Security Policy as follows:

Governance of Enterprise IT

The Company aims to ensure that information technology is effectively utilized as a strategic enabler to support business objectives, manage risks arising from the use of information technology, and enhance organizational performance. The management of IT operations, resources, and information shall be conducted efficiently to support the Company’s policies, strategies, objectives, and risk management framework. Appropriate reporting and monitoring mechanisms shall be in place to ensure that IT governance contributes to achieving business objectives, enhancing competitiveness, and creating value for the Company. At a minimum, the Company shall consider the following practices:

1. IT Risk Management Policy

The Company shall define clear roles and responsibilities for managing risks related to information technology security and cybersecurity. The Director of Information Technology and System Development is responsible for studying, identifying, and proposing technological solutions or approaches to mitigate or manage existing risks, and presenting such measures to management for consideration in accordance with the established governance structure.

The Company shall adopt a structured management approach to IT and cybersecurity risk management in alignment with the internationally recognized NIST Cybersecurity Framework, which consists of five key functions:

  1. Identify – Assess and understand the environment, assets, and risks related to information systems.

  2. Protect – Establish control standards and safeguards to protect systems and data.

  3. Detect – Monitor and identify potential cybersecurity threats or incidents.

  4. Respond – Take appropriate actions upon detection of threats to minimize impact and limit damage.

  5. Recover – Restore systems and services promptly to normal operations.

2. IT Security Policy

The Company shall ensure that the Information Technology Security Policy is formally documented in writing. The policy must be effectively communicated to all relevant parties to ensure proper understanding and compliance, particularly between the Information Technology Department and other internal business units, to promote coordination and support business objectives.

The Company shall review the Information Technology Security Policy at least once annually, or whenever significant changes occur that may impact the Company’s information technology security environment.

Environmental management

Environmental Responsibility Policy

The Board of Directors recognizes the importance of conducting business with due regard to environmental responsibility and sustainable development. The Company has therefore established environmental policies and practical guidelines to ensure that its operations are carried out with accountability toward natural resources and the environment, as follows:

  1. Conduct business operations in compliance with applicable environmental laws, regulations, and policies, while taking into consideration potential impacts on natural resources and the environment. The Company also undertakes regular reviews and performance evaluations.

  2. Promote an organizational culture and environmental awareness among employees at all levels, encouraging cooperation and shared responsibility in environmental management, as well as efficient and sustainable resource utilization.

  3. Support environmental education and training programs for all employees to enhance awareness and participation in environmental stewardship.

  4. Strengthen environmental management systems, including efficient resource utilization, treatment measures, restoration and replacement initiatives, as well as monitoring and preventive actions to minimize environmental impacts in a sustainable manner.

  5. Establish supplier selection practices within the supply chain that prioritize environmentally responsible business operations and align with sustainable development principles.

In accordance with these policies and practices, the Board of Directors acknowledges the value of responsible resource management and environmental stewardship. The Company has therefore established its corporate environmental policies and practices, which are publicly disclosed on the Company’s website at:
https://investor.rph.co.th/storage/document/cg/corporate-environmental-policies-and-practices-th.pdf

https://investor.rph.co.th/storage/document/cg/corporate-environmental-policies-and-practices-th.pdf1-6
Human rights

Human Rights and Diversity Policy

The Board of Directors places great importance on respect for human rights and responsible business conduct. The Company has therefore established a Human Rights Policy and implemented it across the organization, with the following key practices:

  • The Company does not engage in or support any activities that violate human rights in any form.

  • The Company promotes awareness and understanding of human rights principles among employees to ensure appropriate application in their daily work.

  • The Company respects diversity and individual differences without restricting freedom of thought, gender, race, religion, political views, or any other personal characteristics. Employees are encouraged to express opinions responsibly and to avoid statements that may lead to conflict or division within the organization.

  • Communication channels and grievance mechanisms are established to allow employees and stakeholders who believe their rights have been violated or that they have been treated unfairly to submit complaints. All complaints are reviewed and handled fairly and appropriately.

In accordance with these policies and practices, further details are outlined in the Non-Discrimination and Anti-Sexual Harassment Policy and the Human Rights Policy, which are publicly disclosed on the Company’s Investor Relations website under the Corporate Governance Policies and Guidelines section: https://investor.rph.co.th/th/corporate-governance/policies-and-guidelines

Labor Practices

  • The Company ensures that all operations across its branches comply with applicable labor laws and regulations. The Company strictly prohibits illegal labor practices and respects and supports the protection of human rights in all aspects. Stakeholders and related parties are treated fairly and equally without discrimination based on gender, age, race, education, ethnicity, religion, or personal beliefs.

  • Further details are outlined in the Non-Discrimination and Anti-Sexual Harassment Policy and the Human Rights Policy, which are publicly disclosed on the Company’s Investor Relations website under the Corporate Governance Policies and Guidelines section: https://investor.rph.co.th/th/corporate-governance/policies-and-guidelines

  • In addition, the Company promotes equal employment opportunities for persons with disabilities through cooperation agreements with the Employment Office and Rehabilitation Office to support inclusive workforce participation.

Diversity and Non-Discrimination

  • The Company recognizes the value of diverse perspectives, skills, and experiences among its personnel as a key driver of sustainable organizational growth. The Company is committed to fostering a respectful and inclusive workplace where individuals can work together on the basis of mutual respect and acceptance of differences, free from discrimination, harassment, or any form of misconduct. The Company has established the Non-Discrimination and Anti-Harassment Policy and the Diversity and Inclusion Policy as part of its broader Human Rights framework.

  • To promote diversity and inclusion in a manner that benefits both business operations and employees, the Company has adopted the following principles: Leaders are encouraged to listen to and respect diverse viewpoints.

  • Employees are supported in expressing constructive opinions and ideas.

  • A workplace culture based on mutual respect is actively promoted.

  • Employees are encouraged to work collaboratively while embracing diversity.

  • Equal opportunities are provided, including fair recognition and appreciation of employees.

The Company’s Diversity and Inclusion Policy emphasizes the synergy created by integrating diverse backgrounds, including gender, age, ethnicity, culture, experience, perspectives, and professional approaches. This inclusive environment supports the Company’s vision of becoming “a leading private hospital.”

Occupational health and safety

Occupational Health, Safety and Working Environment Policy

The Company places great importance on occupational health, safety, and the working environment. Practical guidelines have been established to ensure safe and sustainable business operations, as follows:

  1. Conduct business operations in compliance with applicable laws, regulations, and policies relating to occupational health, safety, and working conditions, while considering the safety of life and property and the potential health impacts on employees, business partners, and stakeholders. Regular monitoring and safety performance evaluations are carried out.

  2. Promote workplace safety by establishing rules, procedures, and safety standards aligned with operational risks, including continuous improvement of working conditions, work environments, and safe work practices, as well as the provision of adequate personal protective equipment.

  3. Maintain preparedness for emergency situations by developing, conducting drills for, and regularly reviewing emergency response plans to minimize loss of life and property.

  4. Foster a strong safety culture across the organization to ensure sustainable workplace safety practices.

Implementation of Occupational Health and Safety Practices

The Company has established a Safety, Occupational Health and Environmental Committee to oversee and promote workplace safety and health, with key practices as follows:

  1. Communicate policies on quality, environment, safety, and energy conservation to executives, employees, contractors, and relevant parties to enhance awareness and ensure strict compliance with safety standards.

  2. Require employees to complete fundamental safety training from the beginning of employment, and incorporate occupational health and safety performance into the organization’s Key Performance Indicators (KPIs).

  3. Encourage operational staff to perform their duties responsibly, strictly adhere to safety requirements, wear appropriate uniforms and protective equipment, and act as role models for safety practices.

  4. Implement participation programs related to environmental management, occupational health, safety, and workplace environment to promote awareness and employee engagement.

  5. Disseminate health and disease prevention information through internal communication channels, including the RPH Staff system, the Company intranet, and internal media.

  6. Conduct regular workplace safety inspections, with service personnel assigned to monitor and maintain security on a 24-hour basis.

  7. Install fire alarm systems, fire extinguishers, emergency exits, and directional signage throughout the premises.

  8. Promote 5S activities (Big Cleaning Day) to maintain a safe and organized working environment.

  9. Conduct annual fire drills and evacuation exercises with a target participation rate of 100%.

  10. Provide annual training on basic first aid and cardiopulmonary resuscitation (CPR).

  11. Perform random substance abuse testing for employees and contractors to maintain a safe working environment.

  12. Maintain monthly safety performance statistics, with a target of zero fatal workplace accidents.

  13. Include occupational health, safety, and environmental training as part of the annual training plan, with assessment and evaluation processes, aiming for 100% employee participation. Training records are maintained in employee files.

  14. Implement the IPGS program to enhance internal safety standards.

  15. Provide training on prevention of needlestick and sharp-object injuries.

  16. Ensure proper management and disposal of infectious waste and general waste in accordance with healthcare standards.

  17. Promote infection prevention and control measures (Prevention and Control of Infection).

  18. Conduct regular hospital emergency “CODE” drills.

  19. Organize training programs on quality management and clinical safety.

  20. Develop and maintain risk registers at both departmental and organizational levels, with ongoing monitoring and evaluation.

Promoting Compliance with the Code of Conduct

Promotes Compliance by Directors, Executives and Employees

Yes

Description

Process for Promoting Compliance with the Code of Conduct

Ratchaphruek Hospital Public Company Limited (“the Company”) is committed to conducting business in accordance with good corporate governance and ethical business practices. The Company has established its Code of Conduct as a key framework guiding the performance of the Board of Directors, executives, medical professionals, and employees at all levels. This framework aims to cultivate a strong ethical culture and enhance stakeholder confidence. The Company has implemented the following processes to promote compliance with the Code of Conduct:

1) Board Oversight and Tone at the Top

The Board of Directors oversees operations to ensure compliance with the Code of Conduct and establishes clear ethical and corporate governance practices. Senior management serves as role models, reinforcing a culture of transparency, accountability, and integrity throughout the organization.

2) Compliance Framework and Integration into Operations

The Company has formally documented its Code of Conduct and integrated it into its corporate governance policies, risk management framework, internal control system, and anti-corruption policies. These practices align with the Three Lines of Defense concept to ensure systematic and effective implementation.

3) Communication and Ethical Awareness

The Code of Conduct is communicated through internal channels such as the RPH Staff system, intranet platforms, training programs, and corporate culture initiatives to ensure that personnel at all levels understand and apply ethical principles in their daily work, particularly within a patient-centric healthcare environment.

4) Training and Capacity Building

The Company provides ongoing training programs covering business ethics, corporate governance, anti-corruption practices, personal data protection, and medical professional standards. Such training is incorporated into the annual employee development plan.

5) Whistleblowing Mechanism and Protection of Whistleblowers

The Company has established confidential and secure whistleblowing channels, along with appropriate protection measures for whistleblowers. Investigation processes are conducted transparently, fairly, and under the supervision of relevant committees.

6) Monitoring Mechanism and Continuous Improvement

Compliance with the Code of Conduct is monitored through internal controls, internal audit activities, and oversight by the Audit Committee. Policies and practices are regularly reviewed and improved to ensure alignment with legal requirements, professional standards, and CGR best practices.

These processes reflect the Company’s commitment to building an ethical, transparent, and responsible organization toward patients, shareholders, and stakeholders, forming a strong foundation for good corporate governance and sustainable growth.

Key Performance Indicators (KPI) for Ethics and Corporate Governance

To promote practical compliance with the Code of Conduct, the Company has established Ethics and Compliance KPIs aligned with its risk management and corporate governance framework, as follows:

1) Awareness and Training KPIs

  • 100% of employees complete annual training on the Code of Conduct and anti-corruption practices.

  • Supervisory-level executives attend Corporate Governance and Ethics training at least once per year.

  • 100% of new employees complete ethics orientation programs.

2) Compliance KPIs

  • Zero significant violations of the Code of Conduct.

  • Zero corruption cases affecting the organization (Zero Tolerance Policy).

  • Complaint resolution rate within the specified timeframe ≥ 95%.

3) Whistleblowing and Ethical Culture KPIs

  • 100% availability of accessible and publicly disclosed whistleblowing channels.

  • Response to complaints within specified timelines ≥ 100%.

  • Ethical Culture Survey results achieving ≥ 80% confidence level.

4) Board Oversight and Governance KPIs

  • Ethics and Compliance status reported to the Board of Directors or Audit Committee at least once per year.

  • Annual review of the Code of Conduct and related policies.

5) Risk-based Compliance KPIs

  • 100% of high-risk units undergo ethics and anti-corruption risk assessments.

  • Zero incidents of insider information leakage or insider trading violations.

Anti-Corruption Networks & Projects

Joined or Declared Intent to Join Anti-Corruption Networks

No

Networks & Projects Joined

Network / Project
Thai Private Sector Collective Action Against Corruption: CAC
United Nations Global Compact (UNGC)
Participation of anti-Corruption networks and initiatives

Material Changes & Developments in CG

Introduction

In 2025, Ratchaphruek Hospital Public Company Limited (“the Company”) reviewed and enhanced several corporate governance policies and practices to align with the Corporate Governance Code for Listed Companies issued by the Stock Exchange of Thailand. The Company focused on ensuring that governance mechanisms are practical, measurable, and supportive of transparent, accountable, and stakeholder-focused business operations.

The key developments during the year are summarized as follows:

  1. Review and Enhancement of Corporate Governance Policies
    The Board of Directors reviewed the Corporate Governance Policy, Board and Sub-committee Charters, as well as policies relating to business ethics and insider information. These policies were updated to ensure compliance with applicable laws, regulatory requirements, and good governance practices, and were communicated through the Company’s website and internal communication channels.

  2. Establishment of Governance KPI Monitoring
    The Company introduced governance-related key performance indicators (Governance KPIs) to strengthen oversight of Board and organizational performance. These include Board meeting attendance, participation in ethics and governance training, whistleblowing response monitoring, and insider trading prevention, enabling measurable governance performance evaluation.

  3. Enhancement of Board Composition and Structure
    The Board reviewed its Board Skill Matrix and composition to ensure alignment with the Company’s strategic direction. The Board currently consists of 10 directors, including 3 female directors, reflecting diversity in accordance with the Company’s Board Diversity Policy.

  4. Improvement of Shareholder Meeting Practices and Disclosure
    The Company enhanced shareholder meeting processes through electronic meeting systems in accordance with applicable standards, ensuring early disclosure of meeting information and facilitating shareholder participation, including advance nomination of agenda items and director candidates. No agenda items were added outside those disclosed in the meeting invitation.

  5. Director and Executive Development
    The Company continued to support director and executive development through participation in training programs and seminars organized by external institutions such as the Thai Institute of Directors (IOD) and the Stock Exchange of Thailand, enhancing knowledge in governance, risk management, and regulatory compliance.

  6. Strengthening Ethical Communication and Compliance Monitoring
    The Company improved communication of ethics policies via the Intranet and RPH Staff systems, including acknowledgement and acceptance mechanisms. As of the end of 2024, 100% of personnel acknowledged and complied with the policies, and no cases of insider trading misconduct were identified.

These initiatives represent practical and measurable improvements to governance processes and demonstrate the Company’s commitment to strengthening transparency, accountability, and sustainable corporate governance practices in alignment with CGR principles.

Reviewed the CG Policy or Board Charter in the Past Year

Yes

Material Changes or Developments in the Past Year

Yes

Policy Review — Description

Changes and Developments in Corporate Governance in 2025

In 2025, the Board of Directors of Ratchaphruek Hospital Public Company Limited (the “Company”) continued to enhance its corporate governance system, with a focus on proactive governance and measurable governance to ensure that governance practices are effective, transparent, and aligned with the Corporate Governance Report (CGR) principles of the Stock Exchange of Thailand.

1. Enhancing Board Oversight and Governance Maturity

The Board of Directors reviewed the Board Charter, the Code of Business Ethics, and the corporate governance framework in order to strengthen the clarity of roles and responsibilities, the separation of authority between the Board and management, and the systematic oversight of conflicts of interest. The Company also began adopting the concept of a Governance KPI Dashboard as a monitoring tool, with key indicators including:

  • Board Meeting Attendance ≥ 95%

  • Director Training Participation 100%

  • Independent Director Training Completion 100%

  • Ethics Training Completion 100%

  • Whistleblowing Response ≥ 95%

  • Ethical Culture Score ≥ 80%

  • No Insider Trading Case

These indicators enable the Board to monitor governance performance in a concrete manner and reflect the Company’s progress toward a higher level of organizational governance maturity.

2. Development of Board Structure and Board Diversity

The Board of Directors places importance on establishing an appropriate board structure that is aligned with the Company’s strategy. A Board Skill Matrix is used as a tool for annually reviewing the composition of the Board to ensure that directors collectively possess the knowledge, expertise, and experience necessary to support the Company’s business direction.

The Company promotes board diversity in terms of gender, professional experience, specialized knowledge, and governance perspectives in order to strengthen strategic decision-making and balanced oversight.

As of 2025, the Board of Directors consisted of 10 members, comprising:

  • 7 male directors and 3 female directors, with women accounting for 30% of the total Board

  • All 3 female directors serving as independent directors, thereby enhancing independence and checks and balances in governance

  • 5 independent directors and 5 non-executive/company directors, reflecting a balanced structure between independence and effective oversight of management

This structure demonstrates the Company’s commitment to raising its corporate governance standards in line with best practices for listed companies and supporting sustainable organizational development.

3. Development of the Capabilities of Directors and Executives

The Company continuously supports directors in attending training programs organized by external institutions such as the Thai Institute of Directors (IOD) and the Stock Exchange of Thailand (SET). The Company monitors training hours and participation in programs related to:

  • Corporate Governance

  • Risk Management

  • ESG & Sustainability

  • Healthcare Governance

Board Development Outcomes

In 2025, the Company’s continuous policy to strengthen the capabilities of directors and executives resulted in the Board being able to perform its oversight duties more effectively and in alignment with the principles of good corporate governance. Key outcomes included:

  • 100% of directors participated in training programs and knowledge development activities in accordance with the annual director development plan

  • The Board gained deeper understanding of Corporate Governance, Risk Management, ESG, and Healthcare Governance, and was able to apply such knowledge in policy setting and strategic oversight

  • Board effectiveness and governance-based decision-making were strengthened through the application of newly acquired knowledge to risk management and the Company’s sustainability development

  • The Company’s governance structure became better prepared to meet CGR criteria and the best practice guidelines of the Stock Exchange of Thailand

4. Strengthening Ethical Culture and the Compliance System

The Company enhanced its ethics policy communication system through RPH Staff and the Intranet, with acknowledgment and acceptance functions requiring personnel to confirm and sign off on policy receipt. By year-end, personnel at all levels had acknowledged and signed acceptance of the policies at a rate of 100%.

The Company also conducted an Ethical Culture Survey to assess its organizational ethical culture. The survey showed that employee confidence in the Company’s ethical culture was at a level of not less than 80%.

5. Promoting a Risk Management Culture Across the Organization

The Company continuously organized Risk Management training activities for the Board of Directors, executives, and middle management to enhance their knowledge, understanding, and skills in identifying, assessing, monitoring, and managing risks that may affect business operations.

In addition, the Company initiated the internal campaign “Hmm… That’s Risky” to encourage personnel at all levels to participate in observing, reporting, and recognizing potential risks that may arise in day-to-day operations. This initiative helps cultivate a proactive risk management culture and supports preventive action before issues affect the organization.

These activities reflect the Company’s commitment to developing an effective Enterprise Risk Management (ERM) system, while also fostering an organizational culture based on prudence, transparency, and good corporate governance to support stable and sustainable growth.

6. Enhancing Disclosure and Shareholder Engagement

The Company improved its proactive disclosure practices through the Company website and the Stock Exchange’s disclosure system, while also upgrading its shareholder meeting process through electronic systems to promote shareholder rights on an equitable and transparent basis.

During the year, the Company disclosed the notice of the shareholders’ meeting 46 days in advance and held 4 Opportunity Day activities to communicate with investors on a continuous basis.

These developments reflect the Company’s transition from policy-based governance to performance-driven governance, under which governance can be measured systematically. The Board of Directors places importance on monitoring, evaluation, and continuous improvement in order to enhance governance standards in line with best practices for listed companies and to build long-term confidence among shareholders and stakeholders.

Enhancing Supplier Capability and Capacity

The Company places importance on managing relationships with suppliers in a fair and transparent manner, while aiming to foster sustainable mutual growth. The Company has therefore established a policy to enhance supplier capability and capacity in order to improve the quality of products and services, operational standards, safety, and the ability to respond to the Company’s needs. This approach is consistent with the nature of the hospital business, which places strong emphasis on quality of care, patient safety, infection control, data protection, and service continuity.

The Company focuses on developing key suppliers through communication of operational requirements, exchange of information and feedback, performance review meetings, and encouraging suppliers to improve their products, services, or work processes in line with hospital standards. This also includes promoting business ethics, anti-corruption practices, personal data protection, and operations in accordance with ESG principles.

Plans to Develop and Enhance Supplier Capability

In 2025, the Company established plans to continuously promote supplier capability and capacity, covering the following key approaches:

Communication of hospital requirements and operational standards
The Company communicates relevant guidelines and requirements to key suppliers, such as quality and safety standards for services provided within the hospital, infection control measures, requirements for working in hospital areas, data confidentiality, and business ethics requirements.

Performance evaluation and feedback for supplier development
The Company evaluates the performance of key suppliers based on criteria such as product and service quality, timeliness, responsiveness, compliance with requirements, and safety-related considerations. The evaluation results are used to provide feedback and support continuous improvement.

Joint improvement of products, services, and work processes
The Company supports discussions with suppliers to improve products, services, and working methods for greater efficiency. Examples include improving the delivery of medical supplies and materials, enhancing maintenance services for medical equipment, strengthening coordination in information technology systems, and improving the performance of outsourced service providers related to hospital operations.

Promotion of sustainable business practices with suppliers
The Company encourages suppliers to conduct business with due regard to laws, professional standards, safety, occupational health, environmental responsibility, and social responsibility. The Company also promotes adherence to business ethics and anti-corruption principles among its suppliers.

Performance Results in 2025

As a result of the implementation of the above policy and plans, the Company has continuously strengthened collaboration with key suppliers, with significant outcomes as follows:

  • The Company continuously communicated hospital requirements and operational guidelines to key suppliers, resulting in a better understanding among suppliers of the Company’s standards and requirements.

  • The Company monitored and evaluated the performance of key suppliers and used the results to improve the quality of products and services, as well as enhance operational efficiency in working together.

  • Coordination between the Company and its suppliers improved in several areas, including faster response times, improved delivery of products and services, more effective issue resolution, and stronger quality control in line with hospital standards.

  • Certain supplier groups worked together with the Company to improve service approaches and operational processes in support of continuity of medical services, safety of service recipients, and the efficiency of internal management.

  • These efforts helped strengthen positive relationships between the Company and its suppliers and supported efficient, transparent, and sustainable business collaboration.

The Company will continue to enhance its supplier development process by focusing on building long-term partnerships with qualified suppliers, in order to support stable business growth while also improving service standards and the sustainability of the overall supply chain.

Implements the CG Code for Listed Companies

No

CG Code — Description

The Board of Directors has reviewed the Company’s corporate governance policy and practices against the Corporate Governance Code for Listed Companies (CG Code) prescribed by the Securities and Exchange Commission. The Board is of the view that the Company has adopted and applied the CG principles in most material respects, taking into consideration the nature of the business, the size of the organization, and the Company’s operating environment.

In this regard, the Board has resolved to continuously review and improve the Company’s corporate governance policy to ensure alignment with relevant standards, best practices for listed companies, and the Company’s business direction as appropriate.

In 2025, the Company implemented key corporate governance principles in several important areas, including the following:

  1. The Company has established a policy on the tenure of independent directors, providing that an independent director may serve for no longer than 9 consecutive years, in order to promote independence in the performance of duties and effective oversight.

  2. The Company places importance on Board Diversity, with at least 2 female directors serving on the Board, in order to support diversity of perspectives in policy-making and corporate oversight.

  3. The Company has structured the Board to maintain an appropriate balance between executive directors and non-executive directors, thereby strengthening checks and balances and enhancing oversight of management.

  4. The Company has the number and qualifications of independent directors in compliance with the criteria prescribed by the Securities and Exchange Commission.

  5. The Company discloses its policy on Board composition and Board diversity, as well as key information on directors, such as age, gender, educational background, experience, shareholding proportion, years of service, and directorships in other listed companies, through the Annual Report / Form 56-1 One Report and the Company’s website, to ensure that shareholders and stakeholders receive adequate and transparent information.

However, in 2025, there remained certain areas that are still under further development in order to achieve fuller alignment with the CG Code, including the following:

  1. The Chairman of the Board is not an independent director.

  2. The Company has not yet established all recommended sub-committees, including the Nomination Committee, Remuneration Committee, Corporate Governance Committee, and Executive Committee.

  3. The number of Board meetings remains below 6 meetings per year, which is one of the recommended governance practices.

  4. The Company has 5 independent directors out of a total of 10 directors, representing 50% of the total Board, which the Company considers to be an appropriate proportion for ensuring checks and balances and effective corporate governance.

Nevertheless, although the Company is still in the process of further enhancing certain practices to more fully align with all aspects of the CG Code, in the nomination and appointment process the Company carefully considers each director’s qualifications, knowledge, expertise, experience, independence, and suitability. The objective is to ensure that the Board can perform its oversight duties effectively, transparently, and fairly.

The Company believes that the current Board structure and composition remain capable of providing an appropriate balance of power among all groups of directors and support decision-making that takes into account the best interests of the Company, its shareholders, and all stakeholders. The Company will continue to progressively enhance its corporate governance practices in order to raise its governance standards in line with applicable principles and best practices for listed companies.

Other CG Performance & Outcomes

The Board of Directors places great importance on establishing a strong corporate governance system and remains committed to continuously enhancing corporate governance standards. The Company has adopted a management policy that seeks to maintain balance amid changing economic and social conditions, based on the principles of the Sufficiency Economy Philosophy and in alignment with the Corporate Governance Code for Listed Companies.

The Board of Directors, executives, and employees at all levels recognize the importance of complying with good corporate governance principles and are committed to ongoing improvement, while taking into account the interests of all stakeholders. This approach supports business growth alongside balanced social and environmental development.

As a result of such commitment, the Company has received the following AGM Checklist scores from the Thai Investors Association:

  • 2020: 93 points

  • 2021: 96 points

  • 2022: 99 points

  • 2023: 97 points

  • 2024: 97 points

  • 2025: 100 points

Contents